PROTEOMICS INTERNATIONAL LABORATORIES LTD - Announcements

1.32%

38.5¢

Market Cap $64.24M

Healthcare Biotechnology

Proteomics International Laboratories Ltd is an Australia-based medical technology... Proteomics International Laboratories Ltd is an Australia-based medical technology company. The Company is engaged in predictive diagnostics and bioanalytical services. It specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. It focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identified up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

PIQ	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/25	867.52KB	Share
PIQ	OxiDx test detects muscle damage in thoroughbred racehorses	PRICE SENSITIVE	14/07/25	422.07KB	Share
PIQ	AMA grants reimbursement code for Next-Gen PromarkerD test	PRICE SENSITIVE	03/07/25	159.49KB	Share
PIQ	Funding boost for precision diagnostics Proteomics Facility	PRICE SENSITIVE	01/07/25	170.23KB	Share
PIQ	First patent for endometriosis blood test - granted in Japan	PRICE SENSITIVE	30/06/25	153.32KB	Share
PIQ	PromarkerD launched into the US at major diabetes conference	PRICE SENSITIVE	20/06/25	177.25KB	Share
PIQ	Supplementary Prospectus	PRICE SENSITIVE	06/06/25	134.15KB	Share
PIQ	A landmark in non-invasive Esophageal Cancer diagnosis	PRICE SENSITIVE	05/06/25	319.62KB	Share
PIQ	$12 million capital raise completed with oversubscribed SPP	PRICE SENSITIVE	05/06/25	161.95KB	Share
PIQ	PromarkerEndo latest results presented at world congress	PRICE SENSITIVE	26/05/25	1.11MB	Share
PIQ	Chinese patent granted for OxiDx technology	PRICE SENSITIVE	15/05/25	136.3KB	Share
PIQ	Share Purchase Plan Offer Booklet	PRICE SENSITIVE	05/05/25	254.77KB	Share
PIQ	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/25	761.26KB	Share
PIQ	$4.5m placement to launch Promarker diagnostics	PRICE SENSITIVE	22/04/25	2.37MB	Share
PIQ	Trading Halt	PRICE SENSITIVE	16/04/25	632.39KB	Share
PIQ	Pause in Trading	PRICE SENSITIVE	16/04/25	114.21KB	Share
PIQ	Australian patent granted for OxiDx oxidative stress test	PRICE SENSITIVE	28/03/25	162.04KB	Share
PIQ	Response to ASX Aware Query	PRICE SENSITIVE	17/03/25	881.65KB	Share
PIQ	PromarkerD predictive test for DKD launched in Australia	PRICE SENSITIVE	13/03/25	174.19KB	Share
PIQ	PromarkerD outperforms conventional tests--results published	PRICE SENSITIVE	11/03/25	178.38KB	Share
PIQ	Proteomics opens CLIA certified reference laboratory in USA	PRICE SENSITIVE	28/02/25	155.9KB	Share
PIQ	Interim Financial Report and Appendix 4D	PRICE SENSITIVE	26/02/25	782.83KB	Share
PIQ	December 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	21/01/25	1.07MB	Share
PIQ	Novel OxiDx test detects muscle damage in elite athletes	PRICE SENSITIVE	31/12/24	236.5KB	Share
PIQ	Breakthrough results for endometriosis diagnostic blood test	PRICE SENSITIVE	30/12/24	396.53KB	Share
PIQ	Proteomics receives $2.16 million in R&D tax incentive	PRICE SENSITIVE	16/12/24	132.49KB	Share
PIQ	AGM Chairman's Address and Investor Presentation	PRICE SENSITIVE	08/11/24	2.7MB	Share
PIQ	September 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	22/10/24	822.02KB	Share
PIQ	Esophageal cancer diagnostic delivers excellent results	PRICE SENSITIVE	23/09/24	475.62KB	Share
PIQ	Update on commercialisation of PromarkerD in the USA	PRICE SENSITIVE	11/09/24	137.18KB	Share
PIQ	Groundbreaking results for type 1 diabetes and kidney health	PRICE SENSITIVE	23/08/24	166.92KB	Share
PIQ	Preliminary Final Report	PRICE SENSITIVE	23/08/24	1.18MB	Share
PIQ	June 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/07/24	1.19MB	Share
PIQ	Eurobio Scientific to sell PromarkerD DKD test in France	PRICE SENSITIVE	24/06/24	159.37KB	Share
PIQ	Proteomics appoints medical devices sales agency for Europe	PRICE SENSITIVE	17/06/24	159.89KB	Share
PIQ	March 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	17/04/24	599.13KB	Share
PIQ	Proteomics signs with Oxford Univ to validate test for Endo	PRICE SENSITIVE	25/03/24	167.61KB	Share
PIQ	PromarkerD US commercialisation & Promarker pipeline update	PRICE SENSITIVE	18/03/24	124.14KB	Share
PIQ	European patent granted for OxiDx technology	PRICE SENSITIVE	28/02/24	151.82KB	Share
PIQ	Interim Financial Report and Appendix 4D	PRICE SENSITIVE	23/02/24	1MB	Share
PIQ	Study validates biomarkers for endometriosis blood test	PRICE SENSITIVE	01/02/24	1.01MB	Share
PIQ	Study validates biomarkers for oesophageal cancer blood test	PRICE SENSITIVE	01/02/24	870.4KB	Share
PIQ	Proteomics to raise $6.5m through Institutional Placement	PRICE SENSITIVE	23/01/24	267.41KB	Share
PIQ	December 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	23/01/24	800.18KB	Share
PIQ	PromarkerD licence with Omics Global extended to Chile	PRICE SENSITIVE	20/12/23	155.98KB	Share
PIQ	AGM Chairman's Address and Investor Presentation	PRICE SENSITIVE	23/11/23	2.6MB	Share
PIQ	US Medicare confirms reimbursement price for PromarkerD	PRICE SENSITIVE	22/11/23	158.46KB	Share
PIQ	Proteomics receives $1.85 million in R&D tax incentive	PRICE SENSITIVE	09/11/23	125.71KB	Share
PIQ	September 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	26/10/23	797.3KB	Share
PIQ	Reinstatement to Quotation	PRICE SENSITIVE	29/09/23	406.89KB	Share
PIQ	PromarkerD US reimbursement price & Aus regulatory decision	PRICE SENSITIVE	29/09/23	165.54KB	Share
PIQ	Suspension from Quotation	PRICE SENSITIVE	18/09/23	647.01KB	Share
PIQ	Trading Halt	PRICE SENSITIVE	14/09/23	647.55KB	Share
PIQ	New oesophageal cancer test presented at global conference	PRICE SENSITIVE	08/09/23	1.06MB	Share
PIQ	OxiDx platform technology secures patent in Japan	PRICE SENSITIVE	04/09/23	152.66KB	Share
PIQ	Preliminary Final Report	PRICE SENSITIVE	22/08/23	729.91KB	Share
PIQ	June 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	24/07/23	690.38KB	Share
PIQ	Sonic Healthcare USA signs licence for PromarkerD in the US	PRICE SENSITIVE	10/05/23	974.61KB	Share
PIQ	Trading Halt	PRICE SENSITIVE	08/05/23	1.27MB	Share
PIQ	World Endometriosis Congress - New diagnostic test showcased	PRICE SENSITIVE	05/05/23	1.15MB	Share
PIQ	Canagliflozin lowers PromarkerD DKD risk prediction scores	PRICE SENSITIVE	03/05/23	277.17KB	Share
PIQ	March 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	27/04/23	370.23KB	Share
PIQ	Proteomics renews ISO 13485 and ISO 17025 accreditations	PRICE SENSITIVE	17/04/23	141.08KB	Share
PIQ	New endometriosis test presented at international conference	PRICE SENSITIVE	24/03/23	1.33MB	Share
PIQ	Trading Halt	PRICE SENSITIVE	24/03/23	980.05KB	Share
PIQ	PromarkerD application for Australian MBS to be resubmitted	PRICE SENSITIVE	15/03/23	202.69KB	Share
PIQ	Appendix 4D and Interim Financial Report	PRICE SENSITIVE	27/02/23	877.82KB	Share
PIQ	Distribution agreement for PromarkerD in Britain extended	PRICE SENSITIVE	15/02/23	168.45KB	Share
PIQ	December 2022 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/23	560.03KB	Share
PIQ	Letter of intent with Sonic Healthcare USA extended	PRICE SENSITIVE	31/01/23	127.66KB	Share
PIQ	Letter of intent with Sonic Healthcare USA extended	PRICE SENSITIVE	05/01/23	128.95KB	Share
PIQ	CPT PLA reimbursement code approved in US for PromarkerD	PRICE SENSITIVE	03/01/23	889.06KB	Share
PIQ	UK NICE publishes Medtech Innovation Briefing on PromarkerD	PRICE SENSITIVE	14/12/22	263.71KB	Share
PIQ	AGM Chairman's Address and Investor Presentation	PRICE SENSITIVE	24/11/22	1.64MB	Share
PIQ	PromarkerD patent granted in Hong Kong	PRICE SENSITIVE	11/11/22	155.19KB	Share
PIQ	September 2022 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/10/22	650.58KB	Share
PIQ	Precision diagnostics facility receives $2m funding boost	PRICE SENSITIVE	20/10/22	169.39KB	Share
PIQ	Proteomics receives $1.7 million in R&D tax incentive	PRICE SENSITIVE	17/10/22	124.5KB	Share
PIQ	New Oesophageal Cancer Diagnostic shows strong performance	PRICE SENSITIVE	27/09/22	1.05MB	Share
PIQ	Preliminary Final Report	PRICE SENSITIVE	30/08/22	297.21KB	Share
PIQ	OxiDx launched to maximise oxidative stress technology	PRICE SENSITIVE	29/08/22	151.06KB	Share
PIQ	Completion of Placement and Exercise of Performance Rights	PRICE SENSITIVE	22/08/22	213.43KB	Share
PIQ	Proteomics raises $8m in highly successful Placement	PRICE SENSITIVE	15/08/22	256.76KB	Share
PIQ	Trading Halt	PRICE SENSITIVE	11/08/22	636KB	Share
PIQ	Reinstatement to Quotation	PRICE SENSITIVE	09/08/22	408.62KB	Share
PIQ	Proteomics signs binding LOI with Sonic Healthcare USA	PRICE SENSITIVE	09/08/22	155.17KB	Share
PIQ	Suspension from Quotation	PRICE SENSITIVE	08/08/22	441.61KB	Share
PIQ	Trading Halt	PRICE SENSITIVE	04/08/22	637.55KB	Share
PIQ	Clinical Utility Study demonstrates PromarkerD test benefits	PRICE SENSITIVE	02/08/22	167.33KB	Share
PIQ	Potential breakthrough blood test for endometriosis	PRICE SENSITIVE	01/08/22	918.29KB	Share
PIQ	June 2022 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/07/22	720.69KB	Share
PIQ	European PromarkerD patents expanded beyond diabetes	PRICE SENSITIVE	25/07/22	156.32KB	Share
PIQ	Endometriosis clinical validation study readout positive	PRICE SENSITIVE	30/06/22	159.93KB	Share
PIQ	Proteomics secures licence to oesophageal cancer biomarkers	PRICE SENSITIVE	21/06/22	249.11KB	Share
PIQ	PromarkerD manufacturing tech-transfer completed	PRICE SENSITIVE	16/06/22	152.69KB	Share
PIQ	Proteomics awarded $400,000 funding to support manufacturing	PRICE SENSITIVE	12/05/22	158.04KB	Share
PIQ	March 2022 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/04/22	429.48KB	Share
PIQ	New Clinical Advisory Board for PromarkerD global rollout	PRICE SENSITIVE	12/04/22	155.62KB	Share
PIQ	Appendix 4D and Interim Financial Report	PRICE SENSITIVE	24/02/22	572.1KB	Share
PIQ	PromarkerD completes 'pre-assessment' for Medicare rebate	PRICE SENSITIVE	22/02/22	152.17KB	Share

PIQ Quarterly Activities/Appendix 4C Cash Flow Report
28/07/25	PRICE SENSITIVE	867.52KB	Share
PIQ OxiDx test detects muscle damage in thoroughbred racehorses
14/07/25	PRICE SENSITIVE	422.07KB	Share
PIQ AMA grants reimbursement code for Next-Gen PromarkerD test
03/07/25	PRICE SENSITIVE	159.49KB	Share
PIQ Funding boost for precision diagnostics Proteomics Facility
01/07/25	PRICE SENSITIVE	170.23KB	Share
PIQ First patent for endometriosis blood test - granted in Japan
30/06/25	PRICE SENSITIVE	153.32KB	Share
PIQ PromarkerD launched into the US at major diabetes conference
20/06/25	PRICE SENSITIVE	177.25KB	Share
PIQ Supplementary Prospectus
06/06/25	PRICE SENSITIVE	134.15KB	Share
PIQ A landmark in non-invasive Esophageal Cancer diagnosis
05/06/25	PRICE SENSITIVE	319.62KB	Share
PIQ $12 million capital raise completed with oversubscribed SPP
05/06/25	PRICE SENSITIVE	161.95KB	Share
PIQ PromarkerEndo latest results presented at world congress
26/05/25	PRICE SENSITIVE	1.11MB	Share
PIQ Chinese patent granted for OxiDx technology
15/05/25	PRICE SENSITIVE	136.3KB	Share
PIQ Share Purchase Plan Offer Booklet
05/05/25	PRICE SENSITIVE	254.77KB	Share
PIQ Quarterly Activities/Appendix 4C Cash Flow Report
24/04/25	PRICE SENSITIVE	761.26KB	Share
PIQ $4.5m placement to launch Promarker diagnostics
22/04/25	PRICE SENSITIVE	2.37MB	Share
PIQ Trading Halt
16/04/25	PRICE SENSITIVE	632.39KB	Share
PIQ Pause in Trading
16/04/25	PRICE SENSITIVE	114.21KB	Share
PIQ Australian patent granted for OxiDx oxidative stress test
28/03/25	PRICE SENSITIVE	162.04KB	Share
PIQ Response to ASX Aware Query
17/03/25	PRICE SENSITIVE	881.65KB	Share
PIQ PromarkerD predictive test for DKD launched in Australia
13/03/25	PRICE SENSITIVE	174.19KB	Share
PIQ PromarkerD outperforms conventional tests--results published
11/03/25	PRICE SENSITIVE	178.38KB	Share
PIQ Proteomics opens CLIA certified reference laboratory in USA
28/02/25	PRICE SENSITIVE	155.9KB	Share
PIQ Interim Financial Report and Appendix 4D
26/02/25	PRICE SENSITIVE	782.83KB	Share
PIQ December 2024 Quarterly Activities Report and Appendix 4C
21/01/25	PRICE SENSITIVE	1.07MB	Share
PIQ Novel OxiDx test detects muscle damage in elite athletes
31/12/24	PRICE SENSITIVE	236.5KB	Share
PIQ Breakthrough results for endometriosis diagnostic blood test
30/12/24	PRICE SENSITIVE	396.53KB	Share
PIQ Proteomics receives $2.16 million in R&D tax incentive
16/12/24	PRICE SENSITIVE	132.49KB	Share
PIQ AGM Chairman's Address and Investor Presentation
08/11/24	PRICE SENSITIVE	2.7MB	Share
PIQ September 2024 Quarterly Activities Report and Appendix 4C
22/10/24	PRICE SENSITIVE	822.02KB	Share
PIQ Esophageal cancer diagnostic delivers excellent results
23/09/24	PRICE SENSITIVE	475.62KB	Share
PIQ Update on commercialisation of PromarkerD in the USA
11/09/24	PRICE SENSITIVE	137.18KB	Share
PIQ Groundbreaking results for type 1 diabetes and kidney health
23/08/24	PRICE SENSITIVE	166.92KB	Share
PIQ Preliminary Final Report
23/08/24	PRICE SENSITIVE	1.18MB	Share
PIQ June 2024 Quarterly Activities Report and Appendix 4C
30/07/24	PRICE SENSITIVE	1.19MB	Share
PIQ Eurobio Scientific to sell PromarkerD DKD test in France
24/06/24	PRICE SENSITIVE	159.37KB	Share
PIQ Proteomics appoints medical devices sales agency for Europe
17/06/24	PRICE SENSITIVE	159.89KB	Share
PIQ March 2024 Quarterly Activities Report and Appendix 4C
17/04/24	PRICE SENSITIVE	599.13KB	Share
PIQ Proteomics signs with Oxford Univ to validate test for Endo
25/03/24	PRICE SENSITIVE	167.61KB	Share
PIQ PromarkerD US commercialisation & Promarker pipeline update
18/03/24	PRICE SENSITIVE	124.14KB	Share
PIQ European patent granted for OxiDx technology
28/02/24	PRICE SENSITIVE	151.82KB	Share
PIQ Interim Financial Report and Appendix 4D
23/02/24	PRICE SENSITIVE	1MB	Share
PIQ Study validates biomarkers for endometriosis blood test
01/02/24	PRICE SENSITIVE	1.01MB	Share
PIQ Study validates biomarkers for oesophageal cancer blood test
01/02/24	PRICE SENSITIVE	870.4KB	Share
PIQ Proteomics to raise $6.5m through Institutional Placement
23/01/24	PRICE SENSITIVE	267.41KB	Share
PIQ December 2023 Quarterly Activities Report and Appendix 4C
23/01/24	PRICE SENSITIVE	800.18KB	Share
PIQ PromarkerD licence with Omics Global extended to Chile
20/12/23	PRICE SENSITIVE	155.98KB	Share
PIQ AGM Chairman's Address and Investor Presentation
23/11/23	PRICE SENSITIVE	2.6MB	Share
PIQ US Medicare confirms reimbursement price for PromarkerD
22/11/23	PRICE SENSITIVE	158.46KB	Share
PIQ Proteomics receives $1.85 million in R&D tax incentive
09/11/23	PRICE SENSITIVE	125.71KB	Share
PIQ September 2023 Quarterly Activities Report and Appendix 4C
26/10/23	PRICE SENSITIVE	797.3KB	Share
PIQ Reinstatement to Quotation
29/09/23	PRICE SENSITIVE	406.89KB	Share
PIQ PromarkerD US reimbursement price & Aus regulatory decision
29/09/23	PRICE SENSITIVE	165.54KB	Share
PIQ Suspension from Quotation
18/09/23	PRICE SENSITIVE	647.01KB	Share
PIQ Trading Halt
14/09/23	PRICE SENSITIVE	647.55KB	Share
PIQ New oesophageal cancer test presented at global conference
08/09/23	PRICE SENSITIVE	1.06MB	Share
PIQ OxiDx platform technology secures patent in Japan
04/09/23	PRICE SENSITIVE	152.66KB	Share
PIQ Preliminary Final Report
22/08/23	PRICE SENSITIVE	729.91KB	Share
PIQ June 2023 Quarterly Activities Report and Appendix 4C
24/07/23	PRICE SENSITIVE	690.38KB	Share
PIQ Sonic Healthcare USA signs licence for PromarkerD in the US
10/05/23	PRICE SENSITIVE	974.61KB	Share
PIQ Trading Halt
08/05/23	PRICE SENSITIVE	1.27MB	Share
PIQ World Endometriosis Congress - New diagnostic test showcased
05/05/23	PRICE SENSITIVE	1.15MB	Share
PIQ Canagliflozin lowers PromarkerD DKD risk prediction scores
03/05/23	PRICE SENSITIVE	277.17KB	Share
PIQ March 2023 Quarterly Activities Report and Appendix 4C
27/04/23	PRICE SENSITIVE	370.23KB	Share
PIQ Proteomics renews ISO 13485 and ISO 17025 accreditations
17/04/23	PRICE SENSITIVE	141.08KB	Share
PIQ New endometriosis test presented at international conference
24/03/23	PRICE SENSITIVE	1.33MB	Share
PIQ Trading Halt
24/03/23	PRICE SENSITIVE	980.05KB	Share
PIQ PromarkerD application for Australian MBS to be resubmitted
15/03/23	PRICE SENSITIVE	202.69KB	Share
PIQ Appendix 4D and Interim Financial Report
27/02/23	PRICE SENSITIVE	877.82KB	Share
PIQ Distribution agreement for PromarkerD in Britain extended
15/02/23	PRICE SENSITIVE	168.45KB	Share
PIQ December 2022 Quarterly Activities Report and Appendix 4C
31/01/23	PRICE SENSITIVE	560.03KB	Share
PIQ Letter of intent with Sonic Healthcare USA extended
31/01/23	PRICE SENSITIVE	127.66KB	Share
PIQ Letter of intent with Sonic Healthcare USA extended
05/01/23	PRICE SENSITIVE	128.95KB	Share
PIQ CPT PLA reimbursement code approved in US for PromarkerD
03/01/23	PRICE SENSITIVE	889.06KB	Share
PIQ UK NICE publishes Medtech Innovation Briefing on PromarkerD
14/12/22	PRICE SENSITIVE	263.71KB	Share
PIQ AGM Chairman's Address and Investor Presentation
24/11/22	PRICE SENSITIVE	1.64MB	Share
PIQ PromarkerD patent granted in Hong Kong
11/11/22	PRICE SENSITIVE	155.19KB	Share
PIQ September 2022 Quarterly Activities Report and Appendix 4C
31/10/22	PRICE SENSITIVE	650.58KB	Share
PIQ Precision diagnostics facility receives $2m funding boost
20/10/22	PRICE SENSITIVE	169.39KB	Share
PIQ Proteomics receives $1.7 million in R&D tax incentive
17/10/22	PRICE SENSITIVE	124.5KB	Share
PIQ New Oesophageal Cancer Diagnostic shows strong performance
27/09/22	PRICE SENSITIVE	1.05MB	Share
PIQ Preliminary Final Report
30/08/22	PRICE SENSITIVE	297.21KB	Share
PIQ OxiDx launched to maximise oxidative stress technology
29/08/22	PRICE SENSITIVE	151.06KB	Share
PIQ Completion of Placement and Exercise of Performance Rights
22/08/22	PRICE SENSITIVE	213.43KB	Share
PIQ Proteomics raises $8m in highly successful Placement
15/08/22	PRICE SENSITIVE	256.76KB	Share
PIQ Trading Halt
11/08/22	PRICE SENSITIVE	636KB	Share
PIQ Reinstatement to Quotation
09/08/22	PRICE SENSITIVE	408.62KB	Share
PIQ Proteomics signs binding LOI with Sonic Healthcare USA
09/08/22	PRICE SENSITIVE	155.17KB	Share
PIQ Suspension from Quotation
08/08/22	PRICE SENSITIVE	441.61KB	Share
PIQ Trading Halt
04/08/22	PRICE SENSITIVE	637.55KB	Share
PIQ Clinical Utility Study demonstrates PromarkerD test benefits
02/08/22	PRICE SENSITIVE	167.33KB	Share
PIQ Potential breakthrough blood test for endometriosis
01/08/22	PRICE SENSITIVE	918.29KB	Share
PIQ June 2022 Quarterly Activities Report and Appendix 4C
28/07/22	PRICE SENSITIVE	720.69KB	Share
PIQ European PromarkerD patents expanded beyond diabetes
25/07/22	PRICE SENSITIVE	156.32KB	Share
PIQ Endometriosis clinical validation study readout positive
30/06/22	PRICE SENSITIVE	159.93KB	Share
PIQ Proteomics secures licence to oesophageal cancer biomarkers
21/06/22	PRICE SENSITIVE	249.11KB	Share
PIQ PromarkerD manufacturing tech-transfer completed
16/06/22	PRICE SENSITIVE	152.69KB	Share
PIQ Proteomics awarded $400,000 funding to support manufacturing
12/05/22	PRICE SENSITIVE	158.04KB	Share
PIQ March 2022 Quarterly Activities Report and Appendix 4C
28/04/22	PRICE SENSITIVE	429.48KB	Share
PIQ New Clinical Advisory Board for PromarkerD global rollout
12/04/22	PRICE SENSITIVE	155.62KB	Share
PIQ Appendix 4D and Interim Financial Report
24/02/22	PRICE SENSITIVE	572.1KB	Share
PIQ PromarkerD completes 'pre-assessment' for Medicare rebate
22/02/22	PRICE SENSITIVE	152.17KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 38.5¢		Change 0.005(1.32%)		Mkt cap ! $64.24M

Open	High	Low	Value	Volume
38.0¢	40.0¢	38.0¢	$29.12K	74.03K

Buyers (Bids)

No.	Vol.	Price($)
1	9695	38.5¢

Sellers (Offers)

Price($)	Vol.	No.
39.5¢	7256	2

View Market Depth

No.	Vol.	Price($)
1	9695	0.385
3	55088	0.380
1	2666	0.375
3	10756	0.370
1	756	0.365

Price($)	Vol.	No.
0.395	7256	2
0.400	756	1
0.405	4971	2
0.410	100000	1
0.425	2775	1

Last trade - 13.25pm 11/08/2025 (20 minute delay)


Last 38.5¢		Change 0.005 ( 1.32 %)
Open	High	Low	Volume
39.0¢	39.5¢	38.5¢	26255
Last updated 13.51pm 11/08/2025 ?

PIQ (ASX) Chart

PROTEOMICS INTERNATIONAL LABORATORIES LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available